Juliana Quero Reimao
Overview
Explore the profile of Juliana Quero Reimao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva Bellini Ramos A, Torres T, Dos Reis L, Lambert G, Colombo F, Marques M, et al.
Parasitol Res
. 2024 Aug;
123(8):303.
PMID: 39160298
This study investigates the efficacy of nebivolol (NBV) in experimental models of toxoplasmosis, focusing on parasite burden reduction and neuronal protection. In the acute model of experimental toxoplasmosis, Swiss mice...
2.
Diethelm L, da Silva Bellini Ramos A, de Lorena G, Trajano B, Do Espirito Santo R, Barros de Menezes R, et al.
Pharmaceutics
. 2024 Feb;
16(2).
PMID: 38399316
Toxoplasmosis is a globally prevalent zoonotic disease with significant clinical implications, including neurotoxoplasmosis, a leading cause of cerebral lesions in AIDS patients. The current pharmacological treatments for toxoplasmosis face clinical...
3.
Dos Santos B, da Silva Bellini Ramos A, Barros de Menezes R, Scotti M, Colombo F, Marques M, et al.
Parasitology
. 2023 Oct;
150(13):1226-1235.
PMID: 37859414
Toxoplasmosis is a significant public health concern with limited therapeutic options. The medicines for malaria venture (MMV) developed the pandemic response box (PRB) containing 400 drug-like molecules with broad pathogen...
4.
Dos Santos B, da Silva Bellini Ramos A, Barros de Menezes R, Scotti M, Colombo F, Marques M, et al.
PLoS One
. 2023 Jul;
18(7):e0288335.
PMID: 37418497
Toxoplasmosis, caused by the obligate intracellular parasite Toxoplasma gondii, affects about one-third of the world's population and can cause severe congenital, neurological and ocular issues. Current treatment options are limited,...
5.
Barbosa H, Thevenard F, Reimao J, Tempone A, Honorio K, Lago J
Curr Top Med Chem
. 2022 Dec;
23(3):159-213.
PMID: 36515019
Background: Chagas disease (American Trypanosomiasis) is classified by the World Health Organization (WHO) as one of the seventeen neglected tropical diseases (NTD), affecting, mainly, several regions of Latin America. Introduction:...
6.
Cajazeiro D, Toledo P, de Sousa N, Scotti M, Reimao J
Pharmaceutics
. 2022 Aug;
14(8).
PMID: 36015260
is a protozoan that infects up to a third of the world's population. This parasite can cause serious problems, especially if a woman is infected during pregnancy, when toxoplasmosis can...
7.
Reimao J, Coser E, Lee M, Coelho A
Microorganisms
. 2020 Oct;
8(11).
PMID: 33105784
Leishmaniasis is a neglected tropical disease with two main clinical forms: cutaneous and visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the detection and correct identification of the...
8.
Mesquita J, Romanelli M, de Melo Trinconi Trinconi Cm C, Guerra J, Taniwaki N, Uliana S, et al.
Drug Dev Res
. 2020 Aug;
83(2):285-295.
PMID: 32767443
Leishmaniasis remains an important neglected tropical infection caused by the protozoan Leishmania and affects 12 million people in 98 countries. The treatment is limited with severe adverse effects. In the...
9.
Tempone A, Dias Ferreira D, Lima M, Costa Silva T, Borborema S, Reimao J, et al.
Eur J Med Chem
. 2017 Sep;
139:947-960.
PMID: 28881289
The neglected tropical diseases Chagas disease and leishmaniasis affect together more than 20 million people living mainly in developing countries. The mainstay of treatment is chemotherapy, however the drugs of...
10.
Reimao J, Mesquita J, Dias Ferreira D, Tempone A
Evid Based Complement Alternat Med
. 2016 Mar;
2016:1523691.
PMID: 26941821
Leishmaniasis and Chagas disease are neglected parasitic diseases endemic in developing countries; efforts to find new therapies remain a priority. Calcium channel blockers (CCBs) are drugs in clinical use for...